Gene therapy for alpha-1 antitrypsin deficiency: an update
D Pires Ferreira, AM Gruntman… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Altering the human genetic code has been explored since the early 1990s as a
definitive answer for the treatment of monogenic and acquired diseases which do not …
definitive answer for the treatment of monogenic and acquired diseases which do not …
Gene therapy for alpha-1 antitrypsin deficiency: an update
DP Ferreira, AM Gruntman… - Expert opinion on …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Altering the human genetic code has been explored since the early 1990s as a
definitive answer for the treatment of monogenic and acquired diseases which do not …
definitive answer for the treatment of monogenic and acquired diseases which do not …
[PDF][PDF] Gene therapy for alpha-1 antitrypsin deficiency: an update
DP Ferreira, AM Gruntman, TR Flotte - 2023 - researchgate.net
Introduction: Altering the human genetic code has been explored since the early 1990s as a
definitive answer for the treatment of monogenic and acquired diseases which do not …
definitive answer for the treatment of monogenic and acquired diseases which do not …
[PDF][PDF] Gene therapy for alpha-1 antitrypsin deficiency: an update
DP Ferreira, AM Gruntman, TR Flotte - 2023 - researchgate.net
Introduction: Altering the human genetic code has been explored since the early 1990s as a
definitive answer for the treatment of monogenic and acquired diseases which do not …
definitive answer for the treatment of monogenic and acquired diseases which do not …